GlassScriptPhysician profile
Sohyun Boo
NPI 1861698789
$594,516.03
in general payments reported to CMS, 2019-2025
15 companies · $26K in 2025
The $26K reported for 2025 was more than what 92% of Neuroradiology providers received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158K · 2020: $99K · 2021: $106K · 2022: $81K · 2023: $60K · 2024: $65K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $70K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $61K · Travel and Lodging: $16K · Food and Beverage: $3,051 · Gift: $3.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $70,250.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $61,475.00 |
| Travel and Lodging | $16,465.33 |
| Food and Beverage | $3,050.97 |
| Gift | $3.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $473,025.22 | 2019-2025 | Web Aneurysm Embolization System, Hypersoft Advanced, Sofia 6f-131cm Str |
| Stryker Corporation | $76,930.62 | 2019-2025 | Axs Vecta 71, Trevo, Axs Catalyst 7 |
| Medical Device Business Services, INC. | $38,833.24 | 2019-2025 | Emboguard, Trufill, Embotrap |
| Route 92 Medical, INC. | $3,589.45 | 2022-2025 | 8f Base Camp Sheath System |
| Depuy Synthes Sales INC. | $541.90 | 2021-2025 | Emboguard, Cerepak Uniform, Trufill |
| Siemens Medical Solutions USA, INC. | $499.29 | 2022-2025 | Artis Icono Biplane, Artis Icono Floor |
| Medicure Pharma INC. | $400.00 | 2021 | |
| Corindus INC. | $273.24 | 2019 | |
| Boston Scientific Corporation | $141.06 | 2023-2024 | Opticross 35 |
| Penumbra, INC. | $103.83 | 2022-2025 | Ruby Coil, Red 72, Penumbra System |
| Depuy Synthes Products, INC. | $75.29 | 2019 | |
| Medtronic USA, INC. | $48.48 | 2019 | |
| Medtronic, INC. | $27.61 | 2024 | Abre |
| Novartis Pharmaceuticals Corporation | $26.80 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sohyun Boo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.